Back to MetLife Investment Management, LLC MetLife Investment Management, LLC

CORTCORT

Showing 8 of 30 quarters

Position history for MetLife Investment Management, LLCMetLife Investment Management, LLC's holdings in Corcept Therapeutics Incorporated

Yes. MetLife Investment Management holds 5,271 shares of CORT (Corcept Therapeutics), worth $458,313, as of its Q2 2026 13F filing. It reduced the position by 511 shares (-8.8%) from Q1 2026. MetLife Investment Management has held CORT in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$458,313

Current Shares

5,271

Total Value Change

-$1.7M

Total Shares Change

-41,387

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5,271
-8.8%
$458,3130.0%$86.95
0
2026-Q1
Decreased
5,782
-4.7%
$233,0720.0%$40.31
0
2025-Q4
Increased
6,070
+0.9%
$211,2360.0%$34.80
23
2025-Q3
Increased
6,017
+3.0%
$500,0730.0%$83.11
25
2025-Q2
Decreased
5,843
-87.7%
$428,8760.0%$73.40
0
2025-Q1
Decreased
47,363
-3.0%
$5.4M0.0%$114.22
0
2024-Q4
Increased
48,844
+4.7%
$2.5M0.0%$50.39
27
2024-Q3
Decreased
46,658
-0.4%
$2.2M0.0%$46.28
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used